HOME > TOP STORIES
TOP STORIES
-
REGULATORY “New Rules” for Expensive Drugs Could Impact Business Models: Health Insurance Bureau Chief
July 8, 2016
-
BUSINESS Kyorin Anticipates Annual Growth of “at Least 3%” through New Drugs Despite Patent Loss for Kipres: President
July 7, 2016
-
BUSINESS Delving into Securities Filings - 3: Six Companies Report Higher Pay, More Employees
July 6, 2016
-
BUSINESS Delving into Securities Filings - 2: Average Annual Pay at 3 Generic Majors Tops 7 Mil. Yen
July 5, 2016
-
BUSINESS Delving into Securities Filings - 1: 1st and 2nd-Tier Makers Continue to Shed Jobs as Generic Peers See Rise in Workforce
July 4, 2016
-
BUSINESS Filing for 1st Japan-Made Nucleic Acid Expected by Year-End If PIII Yields Positive Data
July 1, 2016
-
BUSINESS Nichi-Iko Aims for 20% Share of Generic Market in “80% Generic Era”: President
June 30, 2016
-
ACADEMIA MHLW Study Group Aims to Formulate Guidelines for Treatment of Skeletal Dysplasias in FY2017
June 29, 2016
-
ACADEMIA Nexium, Takecab Added to Standard Treatments for 1st Eradication of H. Pylori: JSHR Guidelines
June 28, 2016
-
REGULATORY MHLW Vows to Forge Ties with UK Counterpart in Post-Brexit Regulations
June 27, 2016
-
REGULATORY Registration System for Prevention of Dementia to Begin Operation; Will Provide Info on Clinical Research, Trials
June 24, 2016
-
BUSINESS Sanofi’s Antibody Drug for Atopic Dermatitis Close to Regulatory Filing
June 23, 2016
-
BUSINESS Interview: Bayer Yakuhin Chief Spearheading Initiatives to Trigger Behavior Change in Employees
June 23, 2016
-
BUSINESS Bayer Japan Revs Up Drive to Spark Behavior Change, Offers Patient Insights to Back Office Staffers
June 22, 2016
-
REGULATORY Exemption from Bioequivalence Studies Adopted as New Topic at ICH Meeting in Lisbon; Could Affect Generics as Well
June 22, 2016
-
TRENDS Top Global Pharmas Lackluster in Japan while Hep C Drug Makers Flourish
June 21, 2016
-
BUSINESS Aspen Japan Looks to Expand Biz through Essential Drugs, AGs: President
June 20, 2016
-
ACADEMIA No Increased Mortality Risks Seen in Japanese AD Patients on Antipsychotics: Study
June 17, 2016
-
BUSINESS Merck Serono Can Catch Up with Rivals in Immuno-Oncology Space: Japan Oncology Head
June 16, 2016
-
REGULATORY Greater than Expected Need for Drug Discovery Research Using Existing Drugs: AMED Project
June 16, 2016
ページ
Your company’s employer brand is your reputation as an employer and is crucial in attracting top talent. Some reputations are just not good; they may or not be deserved. That is just the perception in the market. Years ago there…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…